Small Cap Feast
Small Cap Feast – 18 May 2020
Dish of the Day:
Diversified Gas & Oil has joined the Main Market from AIM.
Diversified Gas & Oil has joined the Main Market from AIM.
Off the Menu:
EIH has left AIM. Nektan has left AIM after entering administration.
EIH has left AIM. Nektan has left AIM after entering administration.
What’s Cooking in the IPO Kitchen?
The pantry is empty, again!
Conroy Gold & Natural Resources 11.475p £3m (CGNR.L)
Conroy Gold and Natural Resources plc (AIM: CGNR), the gold exploration and development company focused on Ireland, announced that the interpretation of a ground geophysical survey, conducted by Golder Associates prior to the outbreak of Covid-19 on the Clontibret gold deposit, has identified new geological and structural features which are important in regard to controls on high gold grades within the deposit.
New geological and structural features identified
Important factors identified in relation to controls on high gold grades
Approximately 2,000m of ground geophysics completed
Altyn 1.2p £30.2m (ALTN.L)
The State Ecological Expertise Agency of Eastern Kazakhstan’s region has approved the plan of mining operations and environmental impact assessment (OVOS) of the Sekisovskoye deposit.
Specifically, these new permissions regarding environmental emissions and environmental protection measures were granted to Altyn PLC’s subsidiary Baurgold LLP for 2020-2029.
Following this approval Altyn anticipates a successful review over the coming months of addendum #8 of the subsoil contract #555 for the Sekisovskoye deposit with the Ministry of Investment and Infrastructural Development of Kazakhstan for the extension of its contract until 2030.
Oriole Resources 0.315p £2.4m (ORR.L)
Oriole has received a rebate totalling £165k from Her Majesty’s Revenue and Customs in relation to a Research and Development tax relief claim in respect of geoscientific advances sought by the Company through its exploration programmes. The Claim is for the year ended 31 December 2019 (the ‘Period’) and follows the Company’s successful claims for the previous three years (2016 to 2018) where it received a total of c.£145k.
The Claim submitted by the Company continues to demonstrate that it qualifies for the R&D tax relief by performing research work on potential areas of mineralisation in order to build the geological data necessary to prove or disprove the economic feasibility of future mining operations in those areas
Vast Resources 0.165p £17.7m (VAST.L)
£0.9m placing at 0.15p. The cash raised from the Placing and Subscription will be applied to provide immediate funding of the costs of accelerating and expanding the Company’s drilling and metallurgical test work process as outlined in the Company’s announcement of 15 May and for general working capital.
Maestrano Group 1.9p £2.8m (MNO.L)
The Artificial Intelligence platform for transport corridor analytics, announced the appointment of Mr Nicholas Wayne as Vice President Americas.
Nick was most recently a senior executive with Airbus’ Intelligence business in North America. Nick joined Airbus in 2017 as a founding member of Airbus Aerial, a start-up SaaS company that leveraged AI and machine learning to derive insights from a combination of satellite, airplane, and drone imagery. As head of business development, Nick was responsible for all revenue generating activities as well as growing the team and the business at large.
Augean 151.5p £158m (AUG.L)
One of the UK’s leading specialist waste management businesses, announces that it has today lodged a claim with HMRC for repayment of £11.1m of Landfill Tax including interest overpaid in relation to engineering materials used as part of its landfills cell construction (colloquially referred to as the ‘Fluff layer’).
This protects the Augean position in the light of legal challenges brought by other waste site operators that have successfully argued before the Upper Tax Tribunal that they can reclaim LFT accounted for on the ‘Fluff layer’. HMRC has challenged the Upper Tribunal decision and it is expected the matter will be heard in the Court of Appeal at a yet to be determined date. The outcome of that appeal will have a direct bearing on the claim filed by Augean.
Renalytix 345p £205m (RENX.L)
The commercial-stage artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and lower healthcare costs, announces that it has confidentially submitted a draft registration statement on Form F-1 with the Securities and Exchange Commission relating to a proposed dual-listing and public offering of American Depositary Shares, each of which will represent one or a number of the Company’s ordinary shares, on the Nasdaq Stock Market
Arkle Resources 0.925p £1.7m (ARK.L)
£250k placing at 0.75p. The net proceeds raised will be used for further exploration activities at the the Stonepark Zinc Project in Co. Limerick, Ireland and fund other exploration activities, including on the Company’s 100% owned gold exploration projects.
Fast Forward Innovations 6.25p £10.1m (FFWD.L)
FastForward has agreed to invest $1 million in Yooma as part of a $5 million fundraising round at a price of $0.65 per share. This follows the sale of Company’s holding in Entertainment Direct Asia (trading as ‘Yooya’) to Yooma, as announced at 23 April 2020. Following the Investment and the sale of its interest in Yooya, FastForward will hold 3,588,078 shares in Yooma, representing 10.65% of the company, with an implied value of $2,332,000 (circa £1.9 million) based on the subscription price of this $5 million fundraise. On a pro forma basis, in the year to 31 December 2019, the Enlarged Group reported revenue of $451,090, a loss before tax of $537,265 and net assets of $353,000.
Yooma’s business plan includes partnering with some of Pan-Asia’s leading social and e-commerce platforms creating the first Hemp and CBD focused lifestyle company in Asia.
Inland Homes 48p £110m (INL.L)
The brownfield developer, housebuilder and partnership housing company with a focus on the south and south east of England, announces the reopening of its sales and marketing suites from 22 May to support its ongoing online and remote sales and marketing activity. In order to ensure social distancing, visits will be by appointment only and limited to two people from the same household. Perspex screens will be installed on desks where possible and hand sanitiser, face masks and gloves made available to both staff and visitors as additional precautions. Show home surfaces such as door handles, worktops and white goods will be sanitised before and after each viewing.
0203 764 2344
*A corporate client of Hybridan LLP
This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.
The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).
Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.
Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
If you would like to unsubscribe, please email firstname.lastname@example.org with “unsubscribe me”.